ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 171 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $80,000 | +1.3% | 12,200 | 0.0% | 0.02% | +17.6% |
| Q2 2022 | $79,000 | -30.1% | 12,200 | -50.0% | 0.02% | -22.7% |
| Q1 2022 | $113,000 | +79.4% | 24,400 | +100.0% | 0.02% | +100.0% |
| Q4 2021 | $63,000 | -49.6% | 12,200 | 0.0% | 0.01% | -52.2% |
| Q3 2021 | $125,000 | -48.3% | 12,200 | 0.0% | 0.02% | -51.1% |
| Q2 2021 | $242,000 | -28.0% | 12,200 | 0.0% | 0.05% | -33.8% |
| Q1 2021 | $336,000 | +2.4% | 12,200 | 0.0% | 0.07% | -5.3% |
| Q4 2020 | $328,000 | – | 12,200 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $22,344,000 | 10.09% |
| Altium Capital Management LP | 2,515,785 | $12,579,000 | 3.47% |
| Deep Track Capital, LP | 5,641,668 | $28,208,000 | 1.99% |
| Paradigm Biocapital Advisors LP | 839,257 | $4,196,000 | 1.20% |
| SABBY MANAGEMENT, LLC | 940,400 | $4,702,000 | 0.68% |
| Monaco Asset Management SAM | 500,000 | $2,500,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,000,000 | $25,000,000 | 0.52% |
| CVI Holdings, LLC | 1,460,595 | $7,303,000 | 0.48% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $13,566,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,000,000 | $4,960,000 | 0.33% |